Kurt Emster

Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC.

OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds.

Metabolon, Inc. operates as a health technology company. It offers precision medicine, clinical diagnostic, and metabolomics services. The firm serves to the pharmaceutical, biotechnology, consumer product industries. The company was founded in 2000 and is headquartered in Morrisville, NC.

Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA.

Arbor Pharmaceuticals LLC develops pharmaceutical products, which focuses on cardiovascular, hospital and pediatric markets. It offers edarbyclor, cetylev, horizant, zenzedi, evekeo, sklice, and eryhromycin. The company was founded by Jarrett T. Disbrow and Edward J. Schutter and is headquartered in Atlanta, GA.

CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA.

Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA.

River Vision Development Corp. develops novel protein therapies. The firm provides therapy for the treatment of graves orbitopathy which is a condition in which an autoimmune response is mounted against tissues behind the eye, causing inflammation, tissue proliferation and excess production of extracellular matrix. The company was founded in 2011 and is headquartered in New York, NY.

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Bain Capital Ventures LP (Bain Capital Ventures) is a venture capital firm founded in 2001. The firm is headquartered in Boston, Massachusetts with additional offices in New York and California. The firm is wholly owned by Bain Capital LP.

Kohlberg Kravis Roberts & Co. LP (KKR) is a private equity subsidiary of KKR & Co. Inc founded in 1976 by Henry Kravis, George Roberts and Jerome Kohlberg. The firm is headquartered in New York.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Camden Partners Private Equity (Camden Partners) is a private equity subsidiary of Camden Partners Holdings LLC founded in 1995 by David Lyle Warnock. The firm is headquartered in Baltimore, Maryland.

Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD.

eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA.

TPG Special Situations Partners LLC provides financial services. The company is headquartered in Fort Worth, TX.

Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA.

IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA.

Mind-X Corp. designs and develops software application. The firm offers MindX. The company was founded by R. Jacob Vogelstein, Julia Brown, and Emily Caporello Bluvas in 2017 and is headquartered in Bethesda, MD.

Novartis Inflammasome Research, Inc. operates as a biopharmaceutical company, which engages in the development of a suite of NOD-, LRR- and pyrin domain-containing 3 (NLRP3) antagonists for the treatment of inflammatory diseases. It also develops chemically distinct systemic, gut-directed, and central nervous system (CNS)-penetrant drug candidates to address a breadth of indications triggered by NLRP3, including metabolic, fibrotic, autoimmune, autoinflammatory, and neurological diseases. The company was founded by Eicke Latz and Luigi Franchi in 2017 and is headquartered in Boston, MA.

Gigantum, Inc. provides computer software. It offers data science, docker, jupyter and python. The company was founded by Tyler J. Whitehouse, Dean Kleissas, Jacob R. Vogelstein, Randal Burns and Joshua Vogelstein and is headquartered in Washington, DC.

Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA.

Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA.

Headlands Research, Inc. engages in the provision of clinical research services. Its therapeutic areas include allergy, cardiovascular, dermatology, emergency medicine, immunology, internal medicine, nephrology, neurology, obstetrics and gynecology, pediatrics, physical medicine and rehabilitation, urology, and vaccine. The company was founded by Mark Blumling in 2018 and is headquartered in Corte Madera, CA.

IFM Cinque, Inc. is a biotechnology company. The company is headquartered in Boston, MA.

IFM Continua, Inc. engages in the provision of biotechnology services. The company is headquartered in Boston, MA.

IFM Quattro, Inc. is a biotechnology company. The company is headquartered in Boston, MA.

Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC.

Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA.

Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York.

Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021.

Slate Bio, Inc. is a pre-clinical stage biotechnology company that focuses on developing therapies to restore the body's natural immunological response in various diseases. The company is based in Charlottesville, VA. The company's lead compound is a bifunctional IL233 cytokine that augments Tregs and expands tissue resident Tregs. The CEO of the company is Andrew J. Krouse.

Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral.

ICONIQ Capital (ICONIQ) is a private equity and venture capital firm a subsidiary of ICONIQ Capital LLC founded in 2011 by Divesh Kanthylal Makan, Michael Thomas Anders and Chad Louis Boeding. The firm is headquartered in the San Francisco, California.